Retinoblastoma Phase II Expanded Access Clinical Trial
NCT06679634
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Retinoblastoma
Interventions
DRUG:
Chemoplaque also referred to as Episcleral Topotecan
Sponsor
Targeted Therapy Technologies, LLC
Collaborators
[object Object]